CEBPA Methylation as a Prognostic Biomarker in Adult Patients with De Novo AML.

被引：0

作者：

Chen, Hsin-Yu ^{[1
]}

Lin, Tsung-Chin ^{[1
]}

Chou, Wen-Chien ^{[1
]}

Hou, Hsin-An ^{[1
]}

Tien, Hwei-Fang ^{[1
]}

Lin, Liang-In ^{[1
]}

机构：

[1] Natl Taiwan Univ, Taipei 10764, Taiwan

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：628 / 628

页数：1

共 50 条

[1] CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
Lin, T-C
Hou, H-A
Chou, W-C
Ou, D-L
Yu, S-L
Tien, H-F
Lin, L-I
LEUKEMIA, 2011, 25 (01) : 32 - 40
[2] CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
T-C Lin
H-A Hou
W-C Chou
D-L Ou
S-L Yu
H-F Tien
L-I Lin
Leukemia, 2011, 25 : 32 - 40
[3] FLOW CYTOMETRY IMMUNOPHENOTYPING IN CEBPA-DM DE NOVO AML. BIOLOGIC AND PROGNOSTIC RELEVANCE
Fernandez, M.
Pratcorona, M.
Garrido, A.
Estivill, C.
Esteve, J.
Salamero, O.
Tormo, M.
Arnan, M.
Bellosillo, B.
Zamora, L.
Vives, S.
Guardia, R.
Brunet, S.
Sierra, J.
Nomdedeu, J.
HAEMATOLOGICA, 2017, 102 : 673 - 673
[4] Prognostic relevance of myelodysplasia in de novo and secondary AML.
Schaekel, U
Brocard, B
Kroschinsky, F
Schaich, M
Soucek, S
Neubauer, A
Ehninger, G
BLOOD, 2000, 96 (11) : 106A - 106A
[5] Prognostic factors in adult patients with de novo AML. Preliminary results of the GOELAM2 trial.
Harousseau, JL
Witz, B
Lioure, B
Lamy, T
Solary, E
Ifrah, N
Guyotat, D
Abgrall, JF
Cahn, JY
BLOOD, 2000, 96 (11) : 324A - 324A
[6] Prognostic factors in adult AML.
vanPutten, WLJ
Lowenberg, B
BLOOD, 1997, 90 (10) : 283 - 283
[7] Minimal residual disease in adults with de novo AML.
Wormann, B
Konemann, S
Grove, D
Toepker, S
Sauerland, AHB
Buchner, T
Hiddemann, W
Terstappen, LWMM
BLOOD, 1995, 86 (10) : 1313 - 1313
[8] Prognostic impact of CEBPA mutational subgroups in adult AML
Georgi, Julia-Annabell
Stasik, Sebastian
Kramer, Michael
Meggendorfer, Manja
Roellig, Christoph
Haferlach, Torsten
Valk, Peter
Linch, David
Herold, Tobias
Duployez, Nicolas
Taube, Franziska
Middeke, Jan Moritz
Platzbecker, Uwe
Serve, Hubert
Baldus, Claudia D.
Muller-Tidow, Carsten
Haferlach, Claudia
Koch, Sarah
Berdel, Wolfgang E.
Woermann, Bernhard J.
Krug, Utz
Braess, Jan
Hiddemann, Wolfgang
Spiekermann, Karsten
Boertjes, Emma L.
Hills, Robert K.
Burnett, Alan
Ehninger, Gerhard
Metzeler, Klaus
Rothenberg-Thurley, Maja
Dufour, Annika
Dombret, Herve
Pautas, Cecile
Preudhomme, Claude
Fenwarth, Laurene
Bornhaeuser, Martin
Gale, Rosemary
Thiede, Christian
LEUKEMIA, 2024, 38 (2) : 281 - 290
[9] Prognostic impact of CEBPA mutational subgroups in adult AML
Julia-Annabell Georgi
Sebastian Stasik
Michael Kramer
Manja Meggendorfer
Christoph Röllig
Torsten Haferlach
Peter Valk
David Linch
Tobias Herold
Nicolas Duployez
Franziska Taube
Jan Moritz Middeke
Uwe Platzbecker
Hubert Serve
Claudia D. Baldus
Carsten Muller-Tidow
Claudia Haferlach
Sarah Koch
Wolfgang E. Berdel
Bernhard J. Woermann
Utz Krug
Jan Braess
Wolfgang Hiddemann
Karsten Spiekermann
Emma L. Boertjes
Robert K. Hills
Alan Burnett
Gerhard Ehninger
Klaus Metzeler
Maja Rothenberg-Thurley
Annika Dufour
Hervé Dombret
Cecile Pautas
Claude Preudhomme
Laurene Fenwarth
Martin Bornhäuser
Rosemary Gale
Christian Thiede
Leukemia, 2024, 38 : 281 - 290
[10] Allogeneic stem cell transplantation with reduced intensity conditionning regimen (RIC) for adult patients with AML: Same results in secondary and de novo AML.
Milpied, Noel-Jean
Tabrizi, Reza
Guillaume, Thierry
Chevallier, Patrice
Pigneux, Arnaud
Boiron, Jean Michel
Moreau, Philippe
Mahe, Beatrice
Leguay, Thibaut
Bouabdallah, Krimo
Morineau, Nadine
Delaunay, Jacques
Melot, Cyril
Saulquin, Beatrice
Marit, Gerald
Harousseau, Jean Luc
BLOOD, 2006, 108 (11) : 855A - 856A

← 1 2 3 4 5 →